| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |